Proposed Data Collections Submitted for Public Comment and Recommendations, 75168-75169 [2012-30564]

Download as PDF 75168 Federal Register / Vol. 77, No. 244 / Wednesday, December 19, 2012 / Notices response burden is estimated at 2000 hours for 4000 web-based surveys. There are no costs to respondents other than their time. ANNUALIZED BURDEN HOURS Respondents Form name Number of respondents Number of responses per respondent Average burden per response (hrs.) Young adults ................................................... Web-based survey ......................................... 4000 1 30/60 Dated: December 13, 2012. Ron A. Otten, Director, Office of Scientific Integrity (OSI), Office of the Associate Director for Science (OADS), Office of the Director, Centers for Disease Control and Prevention. Proposed Project Million HeartsTM Hypertension Control Challenge—New—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). [FR Doc. 2012–30563 Filed 12–18–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60-Day–13–13EP] sroberts on DSK5SPTVN1PROD with Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–7570 or send comments to Ron Otten, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an email to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. VerDate Mar<15>2010 18:26 Dec 18, 2012 Jkt 229001 Background and Brief Description Cardiovascular disease is a leading cause of death for men and women in the United States, among the most costly health problems facing our nation today, and among the most preventable. Heart disease and stroke also contribute significantly to disability. High blood pressure, also known as hypertension, is one of the leading causes of heart disease and stroke. Currently, about 67 million American adults have high blood pressure but fewer than half (46%) have adequately controlled blood pressure. The costs of hypertension and its associated diseases are estimated at $156 billion annually, including the cost of medical care and the cost of lost productivity. In September 2011, CDC launched the Million HeartsTM initiative with the goal of preventing one million heart attacks and strokes by 2017. In order to achieve this goal, at least 10 million more Americans must have their blood pressure under control. Toward this end, Million HeartsTM is promoting clinical practices that are effective in increasing blood pressure control among patient populations. There is scientific evidence that provides general guidance on the types of system-based changes to clinical practice that can improve patient blood pressure control, but more information is needed to fully understand implementation practices so that they can be shared and promoted. In May 2013, CDC proposes to launch the Million HeartsTM Hypertension Control Challenge to identify clinical practices and health systems that have been successful in achieving high rates of hypertension control and to develop models for dissemination. The most successful clinical practices or health plans will be recognized as Million HeartsTM Hypertension Control Champions and will receive a cash PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 award of $5,000–$15,000. Recognition will be provided to two groups of practices: Those that represent fewer than 50,000 covered lives, and those that represent 50,000 or more covered lives. Providers eligible to apply for recognition include single practice providers, group practice providers, and healthcare systems. The Challenge is authorized by Public Law 111–358, the America Creating Opportunities to Meaningfully Promote Excellence in Technology, Education and Science Reauthorization Act of 2010 (COMPETES Act). CDC requests OMB approval to collect the information needed to identify, qualify, and rank applicants for recognition through the Million HeartsTM Hypertension Control Challenge. Interested providers or clinical programs may voluntarily selfnominate their practice or healthcare system by completing a web-based nomination form located on the Challenge.gov web portal. The nomination process will include submission of the minimum amount of data needed to provide evidence of clinical success in achieving hypertension control, including: (a) Two point-in-time measures of the clinical hypertension control rate for the patient population, (b) the size of the clinic population served, and (c) a description of the sustainable systems adopted to achieve hypertension control rates. The estimated burden for completing the nomination form is 30 minutes. CDC scientists or contractors will assign a preliminary score to each submitted nomination form. Those with the highest preliminary scores will be further reviewed by a CDC-sponsored panel of three to five experts in hypertension control. The panel will provide CDC with a ranked list of nominees recommended for recognition through the Million HeartsTM Hypertension Control Challenge. Finalists will be asked to participate in a data verification process so that CDC can verify the information submitted on the nomination form. The estimated burden to the respondent is one hour, which includes time to review E:\FR\FM\19DEN1.SGM 19DEN1 75169 Federal Register / Vol. 77, No. 244 / Wednesday, December 19, 2012 / Notices the nomination form with a reviewer or abstractor in person or by phone, and to describe to the reviewer how information was obtained from electronic records, chart reviews, or other sources. Finalists may be eliminated based on the results of data verification. Each remaining finalist, or Champion, will be asked to participate in a semistructured interview. The interview will provide detailed information about the strategies employed by the practice or health system to achieve exemplary rates of hypertension control, including barriers and facilitators for those strategies. The interview will focus on systems and processes and should take no preparation time by the finalist. The estimated burden to the respondent is two hours, which includes time to review the interview protocol with the interviewer, respond to the interview questions, and review qualitative data. OMB approval is requested for three years. On an annual basis, CDC estimates that information will be collected from 1,750 nominees using the nomination form, at most 30 data verification forms, and at most 30 semistructured interviews that include review of qualitative data. The number of Champions recognized in the first year of the challenge may be less than 30. As the Challenge becomes known, the number of recognized Champions may increase to a maximum of 30. The overall goal of the Million HeartsTM initiative is to improve the quality of care delivered to hypertensive patients. CDC will use the information collected through the Million HeartsTM Hypertension Control Challenge to increase widespread attention to hypertension at the clinical practice level, improve understanding of successful implementation strategies at the health system level, bring prestige to organizations that invest in hypertension control, and motivate individual practices to strengthen their hypertension control efforts. Although some providers and healthcare systems routinely provide data on hypertension control rates to entities such as quality improvement committees, these entities do not collect or disseminate information about the clinic processes used to achieve hypertension control. Information collected through the Million HeartsTM Hypertension Control Challenge will link success in clinical outcomes of hypertension control with information about procedures that can be used to achieve similar favorable outcomes. The Challenge will allow interested providers and health care systems to replicate successful the strategies. Participation is voluntary and there are no costs to respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Number of responses per respondent Number of respondents Avg. burden per response (in hr) Total burden (in hr) Type of respondent Form name Physicians (Single or Group Practices). Finalists ............................................. Selected Champion ........................... Million HeartsTM Hypertension Control Champion Nomination form. Data Verification Form ..................... Semi-structured Interview ................ 1,750 1 .5 875 30 30 1 1 1 2 30 60 Total ........................................... ........................................................... ........................ ........................ ........................ 965 Dated: December 13, 2012. Ron A. Otten, Director, Office of Scientific Integrity (OSI), Office of the Associate Director for Science (OADS), Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2012–30564 Filed 12–18–12; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket Number CDC–2012–0014; NIOSH– 260] Silver Nanoparticles (AgNPs); Information and Comment Request National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). sroberts on DSK5SPTVN1PROD with AGENCY: Request for information and comment. ACTION: VerDate Mar<15>2010 16:35 Dec 18, 2012 Jkt 229001 The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), as part of its mission to investigate new and emerging hazards, has initiated an evaluation of the scientific data on silver nanoparticles (AgNPs) to ascertain the potential health risks to workers and to identify gaps in knowledge so that appropriate laboratory and field research studies can be conducted. NIOSH has identified a number of relevant publications on AgNPs. This listing (Evaluation of the scientific data on silver nanoparticles (AgNPs) can be found in Docket CDC–2012–0014 at https://www.regulations.gov. NIOSH is requesting additional information on the following: (1) Published and unpublished reports and findings from in vitro and in vivo toxicity studies with AgNPs, (2) information on possible health effects observed in workers exposed to AgNPs, (3) information on workplaces and products in which AgNPs can be found, (4) description of work tasks and scenarios with a potential for exposure, (5) information on measurement SUMMARY: PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 methods and, workplace exposure data, and (6) information on control measures (e.g., engineering controls, work practices, PPE) that are being used in workplaces where potential exposures to AgNPs occur. Electronic or written comments must be received on or before February 19, 2013. DATES: You may submit comments, identified by CDC–2012–0014 and docket number NIOSH–260, by any of the following methods: • Federal eRulemaking Portal: https:// www.regulations.gov. Follow the instructions for submitting comments. • Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS–C34, 4676 Columbia Parkway, Cincinnati, OH 45226. All information received in response to this notice must include the agency name and docket number (CDC–2012– 0014; NIOSH–260). All relevant comments received will be posted without change to www.regulations.gov, including any personal information provided. For access to the docket to read background documents or ADDRESSES: E:\FR\FM\19DEN1.SGM 19DEN1

Agencies

[Federal Register Volume 77, Number 244 (Wednesday, December 19, 2012)]
[Notices]
[Pages 75168-75169]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-30564]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60-Day-13-13EP]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-7570 or 
send comments to Ron Otten, 1600 Clifton Road, MS-D74, Atlanta, GA 
30333 or send an email to omb@cdc.gov.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Million HeartsTM Hypertension Control Challenge--New--
National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    Cardiovascular disease is a leading cause of death for men and 
women in the United States, among the most costly health problems 
facing our nation today, and among the most preventable. Heart disease 
and stroke also contribute significantly to disability. High blood 
pressure, also known as hypertension, is one of the leading causes of 
heart disease and stroke. Currently, about 67 million American adults 
have high blood pressure but fewer than half (46%) have adequately 
controlled blood pressure. The costs of hypertension and its associated 
diseases are estimated at $156 billion annually, including the cost of 
medical care and the cost of lost productivity.
    In September 2011, CDC launched the Million HeartsTM 
initiative with the goal of preventing one million heart attacks and 
strokes by 2017. In order to achieve this goal, at least 10 million 
more Americans must have their blood pressure under control. Toward 
this end, Million HeartsTM is promoting clinical practices 
that are effective in increasing blood pressure control among patient 
populations. There is scientific evidence that provides general 
guidance on the types of system-based changes to clinical practice that 
can improve patient blood pressure control, but more information is 
needed to fully understand implementation practices so that they can be 
shared and promoted.
    In May 2013, CDC proposes to launch the Million HeartsTM 
Hypertension Control Challenge to identify clinical practices and 
health systems that have been successful in achieving high rates of 
hypertension control and to develop models for dissemination. The most 
successful clinical practices or health plans will be recognized as 
Million HeartsTM Hypertension Control Champions and will 
receive a cash award of $5,000-$15,000. Recognition will be provided to 
two groups of practices: Those that represent fewer than 50,000 covered 
lives, and those that represent 50,000 or more covered lives. Providers 
eligible to apply for recognition include single practice providers, 
group practice providers, and healthcare systems. The Challenge is 
authorized by Public Law 111-358, the America Creating Opportunities to 
Meaningfully Promote Excellence in Technology, Education and Science 
Reauthorization Act of 2010 (COMPETES Act).
    CDC requests OMB approval to collect the information needed to 
identify, qualify, and rank applicants for recognition through the 
Million HeartsTM Hypertension Control Challenge. Interested 
providers or clinical programs may voluntarily self-nominate their 
practice or healthcare system by completing a web-based nomination form 
located on the Challenge.gov web portal. The nomination process will 
include submission of the minimum amount of data needed to provide 
evidence of clinical success in achieving hypertension control, 
including: (a) Two point-in-time measures of the clinical hypertension 
control rate for the patient population, (b) the size of the clinic 
population served, and (c) a description of the sustainable systems 
adopted to achieve hypertension control rates. The estimated burden for 
completing the nomination form is 30 minutes.
    CDC scientists or contractors will assign a preliminary score to 
each submitted nomination form. Those with the highest preliminary 
scores will be further reviewed by a CDC-sponsored panel of three to 
five experts in hypertension control. The panel will provide CDC with a 
ranked list of nominees recommended for recognition through the Million 
HeartsTM Hypertension Control Challenge.
    Finalists will be asked to participate in a data verification 
process so that CDC can verify the information submitted on the 
nomination form. The estimated burden to the respondent is one hour, 
which includes time to review

[[Page 75169]]

the nomination form with a reviewer or abstractor in person or by 
phone, and to describe to the reviewer how information was obtained 
from electronic records, chart reviews, or other sources. Finalists may 
be eliminated based on the results of data verification.
    Each remaining finalist, or Champion, will be asked to participate 
in a semi-structured interview. The interview will provide detailed 
information about the strategies employed by the practice or health 
system to achieve exemplary rates of hypertension control, including 
barriers and facilitators for those strategies. The interview will 
focus on systems and processes and should take no preparation time by 
the finalist. The estimated burden to the respondent is two hours, 
which includes time to review the interview protocol with the 
interviewer, respond to the interview questions, and review qualitative 
data.
    OMB approval is requested for three years. On an annual basis, CDC 
estimates that information will be collected from 1,750 nominees using 
the nomination form, at most 30 data verification forms, and at most 30 
semi-structured interviews that include review of qualitative data. The 
number of Champions recognized in the first year of the challenge may 
be less than 30. As the Challenge becomes known, the number of 
recognized Champions may increase to a maximum of 30.
    The overall goal of the Million HeartsTM initiative is 
to improve the quality of care delivered to hypertensive patients. CDC 
will use the information collected through the Million 
HeartsTM Hypertension Control Challenge to increase 
widespread attention to hypertension at the clinical practice level, 
improve understanding of successful implementation strategies at the 
health system level, bring prestige to organizations that invest in 
hypertension control, and motivate individual practices to strengthen 
their hypertension control efforts. Although some providers and 
healthcare systems routinely provide data on hypertension control rates 
to entities such as quality improvement committees, these entities do 
not collect or disseminate information about the clinic processes used 
to achieve hypertension control. Information collected through the 
Million HeartsTM Hypertension Control Challenge will link 
success in clinical outcomes of hypertension control with information 
about procedures that can be used to achieve similar favorable 
outcomes. The Challenge will allow interested providers and health care 
systems to replicate successful the strategies.
    Participation is voluntary and there are no costs to respondents 
other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of      Avg. burden
      Type of respondent            Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent        (in hr)         (in hr)
----------------------------------------------------------------------------------------------------------------
Physicians (Single or Group     Million HeartsTM           1,750               1              .5             875
 Practices).                     Hypertension
                                 Control
                                 Champion
                                 Nomination form.
Finalists.....................  Data                          30               1               1              30
                                 Verification
                                 Form.
Selected Champion.............  Semi-structured               30               1               2              60
                                 Interview.
                                                                                                 ---------------
    Total.....................  ................  ..............  ..............  ..............             965
----------------------------------------------------------------------------------------------------------------


    Dated: December 13, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI), Office of the Associate 
Director for Science (OADS), Office of the Director, Centers for 
Disease Control and Prevention.
[FR Doc. 2012-30564 Filed 12-18-12; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.